What to Expect at the Premier Proteomics-Dedicated Forum in 2026
Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2027 event, please get in touch at info@hansonwade.com
As proteomics increasingly becomes an integral step in drug discovery workflows, there’s never been a more important time to adapt your methodologies to achieve optimal throughput and sensitivity.
The most recent Proteomics Based Drug Discovery Summit dedicated itself to delivering cutting-edge insights into data analysis technologies, advanced proteomics instruments and sample processing strategies.
The 2026 program was been built with proteomics decision makers working across a plethora of modalities to equip you with the tools and techniques to transform your discovery pipelines with unique insights.
Unmissable Event Highlights
Maximize Throughput Without Compromising Sensitivity
Achieve proteomics workflows at an unprecedented scale with optimized analysis methodologies, whilst capturing the depth and breadth of the proteome, with Eisai and Light Horse Therapeutics
Illuminate Post-Translational Modifications
Understand disease signatures by capturing the dynamics of PTMs with highly accurate proteomics instruments, with lessons from Blueprint Medicines and Merck
Unlock Holistic Health Insights With Multi-Omics
Implement multi-omics into drug discovery to contextualize proteomics insights & make well-informed drug discovery decisions with RyboDyn & Cellarity
Optimize & Automate Sample Processing
Work effectively with challenging samples and implement automation to maintain sample integrity and meet the demand for high throughput proteomics, with AstraZeneca and Sanofi
Achieve Gold-Standard Data Analysis Methodologies
Standardize large-scale proteomics analysis and draw impactful biomedical conclusions whilst storage, sharing and visualizing data securely, with Johnson & Johnson, and Northeastern
Explore Immunopeptidomics, Single-Cell & Spatial Proteomics
Achieve nuanced proteomics understanding to suit your drug discovery goals, unlocking unique insights into the proteome with Aethon Therapeutics, DISCO Pharmaceuticals and Immatics
What was new for 2026?
1 Technical Workshops
- Sample Processing & Automation
Senior Speaker Faculty
- 79% of Director-Level Speakers or Above
More Modalities, More Breakthroughs
- ADCs, Bispecifics, Covalent Inhibitors, Small Molecules, TPD
Explore the 2026 Event Guide
- Hear from the 100% brand-new speakers that joined us in 2026, sharing case studies on mass spectrometry, chemoproteomics, single-cell, and spatial proteomics platforms
- Uncover drug discovery applications across bispecifics, covalent small molecules, TPD, and more
- Review real-life examples on balancing throughput, coverage, and sensitivity of proteomic workflows
2026 Attending Companies Included
Explore the 2026 Agenda
Hear the latest breakthroughs in throughput, coverage, and sensitivity of proteomics methodologies, uncover data-driven presentations, and engage in panel discussions on translating large-scale proteomics data into meaningful drug discovery conclusions.
Partner With Us
Position yourself alongside other proteomics, mass spectrometry and data analysis solution providers, demonstrating your capabilities and increasing your brand awareness to a room full of proteomics decision makers.
Join Biopharma Experts
Be part of cutting-edge discussions with fellow proteomics pioneers to transform drug discovery across a range of modalities, whether you’re working on TPD, ADCs, small molecules, or beyond.